DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Goto S, Ogawa H, Takeuchi M et al.
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease.
Eur Heart J 2010;
31: 2601-2613
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.